News und Analysen
Is Amgen Stock a Buy?
Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more
Why Semiconductor Stocks Broadcom, AMD, and Arm Holdings Rallied Today
Shares of major semiconductor stocks Broadcom (NASDAQ: AVGO), Advanced Micro Devices (NASDAQ: AMD), and Arm Holdings (NASDAQ: ARM) rallied on Tuesday, rising 3%, 3.9%, and 5.3%, respectively.
Chip
Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales.
However
Which S&P 500 Move Matters?
In this podcast, Motley Fool analyst Nick Sciple and host Mary Long discuss:
Mesoblast CEO Silviu Itescu joins Motley Fool host Ricky Mulvey for a conversation about how to price medical treatments
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies. Let's consider two corporations that could help you do
AT&T Stock Nears 52-Week High, But Is It Too Late to Buy?
AT&T (NYSE: T) is making waves again, climbing toward its 52-week high and locking in billion-dollar fiber deals. With rising cash flow, solid dividends, and 5G ambitions, is this legacy telecom
Where Will AT&T Stock Be in 1 Year?
The 2020s did not start well for AT&T (NYSE: T) stock.
In the 2010s, the company veered from the wireless-focused business models of its competitors and invested heavily in non-core businesses such
Stock-Split Watch: Is AT&T Next?
The stock market isn't having a great year, with the S&P 500 down 0.4% at the time of this writing. Not all companies have been equally affected by tariff announcements and the possibility of a
Better Artificial Intelligence Stock: AT&T vs. Palantir Technologies
Nearly every company that's even remotely related to the tech industry is betting that artificial intelligence (AI) will be a key driver of their business in the coming years. This is giving
Down 63%, Should You Buy the Dip on Pfizer?
It's been a tough go for Pfizer (NYSE: PFE). Shares of the pharmaceutical giant are down over 60% from their highs, a multi-year slide since pandemic-related sales peaked a few years ago. But that's
AT&T Bets $5.75 Billion on Fiber Expansion
Telecom giant AT&T (NYSE: T) doubled down on its fiber internet strategy on Wednesday with a $5.75 billion deal to acquire Lumen's Mass Markets fiber business. The acquisition will come with
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now
The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500 index fell nearly 20% from highs made in February, only to make a full recovery
3 High-Flying Stocks That Could Soar Even More
Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.
Three Fool.com contributors think they've found high-flying biotech
Does the 23andMe Acquisition Make Regeneron a Buy Now?
Have you ever wondered if an established drugmaker could do better at genetics-guided research than a consumer-focused diagnostics business? Well, we could find out.
Recently, Regeneron (NASDAQ:
1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
Most people like to buy products when prices are cheaper. That's why you'll probably see lots of car dealers, furniture stores, and retailers advertising special sales during the Memorial Day
Pfizer Stock Analysis: Buy, Sell, or Hold?
Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities.
*Stock prices used were the afternoon prices of May 20, 2025. The video was published on May 22, 2025.
2 Dividend Stocks to Buy With $500 and Hold Forever
Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row
Medtronic (NYSE: MDT) has been a dividend stalwart for decades. The medical device maker recently raised its dividend payment, extending its growth streak to 48 straight years. That means it is two
Better Weight Loss Stock: Amgen or Viking Therapeutics?
Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders in this area, Eli Lilly and Novo Nordisk. However, several other
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
2 Artificial Intelligence (AI) Stocks That May Have a Hard Time Bouncing Back From President Trump's Trade War
No one knows where President Trump's trade war will go next.
Despite the stock market's recovery from the April "Liberation Day" crash, there are a number of high-profile companies that remain
Why Did UnitedHealth CEO Andrew Witty Resign?
These are the reasons that led to the resignation of UnitedHealth (NYSE: UNH) CEO Andrew Witty.
*Stock prices used were the afternoon prices of May 19, 2025. The video was published on May 21, 2025.
Why UnitedHealth Stock Sank Again Today
Shares of UnitedHealth Group (NYSE: UNH) plummeted again on Wednesday. The company's stock is down 5.8% as of market close, while the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: